F&d

Formulation & Development Our Formulation & Development Technique of AXA Parenterals... Read More

Business Division

Business Division AXA Pareterals is a Flagship Company with its Various Division Read More

Formulations

FormulationsProduct Formulation at AXA Parenterals... Read More

CMS

CMS AXA Parenterals Offers Contract Manufacturing Service Read More

Skip Navigation LinksHome Page > About Us > About AXA Parenterals ltd.
   
         Products Offered
Axa Parenterals Ltd. – The Flagship Company

Axa Parenteral Ltd. Axa parenterals Ltd. is WHO-GMP accredited company designed as per US USFDA & EU guidelines to comply with regulated market. Approaching to the African and CIC countries and well stablished in south East Asian nations. We act in a comprehensive regulatory framework for prescription with an ultra modernized plant well equipped with modern technology, having a land area of 1,45,000 sq. feet and constructed area of 2,80,000 sq. feet in two floors, We have emerged as leader across all its business and have established a footprint with customers.

We are mainly indulged in the :

  • Domestic Operations
  • Contract Manufacturing Services
  • Branded Ethical Formulation
  • P2P (Product to procurement) manufacturing

The commitment of “Saving Life With Every Infusion” drives us to expand rapidly towards all facets of human well being and development. Axa is the listed and certified organisation, it support a personal base of over 500 employees globally, which is expected to grow up to 1000 by the end of 2015.

Infrastructure

The company is equipped with four “ Form - Fill - Seal” machineries by Rommelag, Germany and Willer, USA the global leaders in this technology. We are equipped with two FFS machines for LVP and two for SVP. The Containers are blown, filled with the sterile solution and sealed in closed circuit under most aseptic condition, which is totally devoid of any human touch, The aseptically sealed bottles are further sterilized in sophisticated superheated sterilizer at the temperature opf 108 degree centigrade.

Production Capacity

The company is presently capable of producing 50 million bottles per annum of 100 ml to 500 ml, and other 50 million vials of 5ml, 10 ml, 20 ml & 30 ml sizes.

Packing

The most modern state of the art FFS technology packed in aseptic and esthetic special containers (Medigrade).

Advantage
  • Manufactured by world class AFFS technology
  • No chance of contamination
  • Internationally acclaimed IV bottle
  • Self collapsible bottle
  • Nipple/ Euro head
  • Crown protector cap

 
   
  • STRATEGIC ALLIANCE

    Strategic Alliance

    With the prudent decisions of Management, AXA Parenterals Ltd. has made its associations..Strategic Alliance

  • LVP / SVP

    LVP / SVP

    Dextrose injection, Sodium Chloride, Sodium Chloride, Ciprofloxacin Injection ..LVP / SVP

  • ACCREDITATION

    Accreditation

    WHO-GMP Certified, "CE" Certified, NAFDAC Certified, FDA Uganda Certified, MOH Nepal.. Accreditation

  • GROUP INDUSTRIES

    Group Industries

    Axa Parenterals Ltd. Is a large conglomerate with diversified presence into ...Group Industries